Acne Scar Management: Minoxidil as a Promising Approach or a Mirage?

Ramadan S. Hussein, Salman Bin Dayel

International Journal of Biomedicine. 2023;13(3):54-58.
DOI: 10.21103/Article13(3)_RA5
Originally published September 5, 2023


Atrophic and hypertrophic scars can result from various conditions, such as acne, trauma, and surgery. Minoxidil, a medication used for the treatment of severe hypertension and hair loss, has been explored as a potential treatment for scars. This review aims to evaluate the current evidence regarding the role of minoxidil in the treatment of scars. Previously published reviews have primarily focused on the use of minoxidil in hair loss and have only briefly mentioned its potential use for scars. However, minoxidil may have a beneficial effect as an antifibrotic agent. Several studies have reported reduced collagen accumulation and fibrosis after treatment with minoxidil. The proposed mechanism of action is inhibition of the production of lysyl hydroxylases (LHs), which modify and cross-link proteins by converting lysine to hydroxylysine, making collagen more resistant to degradation. Minoxidil, as an LH inhibitor, has been shown to potentially benefit wound healing and regeneration in vitro by inhibiting the proliferation and migration of fibroblasts. To date, direct studies of the efficacy of minoxidil in treating acne scars have not been conducted; however, its inhibitory effects on fibroblast function and antifibrotic outcomes in some in vivo studies suggest that such use may be considered.

acne • scar • minoxidil • treatment
  1. Tan J, Beissert S, Cook-Bolden F, Chavda R, Harper J, Hebert A, Lain E, Layton A, Rocha M, Weiss J, Dréno B. Impact of Facial Atrophic Acne Scars on Quality of Life: A Multi-country Population-Based Survey. Am J Clin Dermatol. 2022 Jan;23(1):115-123. doi: 10.1007/s40257-021-00628-1.
  2. Connolly D, Vu HL, Mariwalla K, Saedi N. Acne Scarring-Pathogenesis, Evaluation, and Treatment Options. J Clin Aesthet Dermatol. 2017 Sep;10(9):12-23. 
  3. Gupta AK, Charrette A. Topical Minoxidil: Systematic Review and Meta-Analysis of Its Efficacy in Androgenetic Alopecia. Skinmed. 2015 May-Jun;13(3):185-9. 
  4. Choi N, Shin S, Song SU, Sung JH. Minoxidil Promotes Hair Growth through Stimulation of Growth Factor Release from Adipose-Derived Stem Cells. Int J Mol Sci. 2018 Feb 28;19(3):691. doi: 10.3390/ijms19030691.
  5. Sung CT, Juhasz ML, Choi FD, Mesinkovska NA. The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review. J Drugs Dermatol. 2019 Feb 1;18(2):155-160. 
  6. Bhargava S, Cunha PR, Lee J, Kroumpouzos G. Acne Scarring Management: Systematic Review and Evaluation of the Evidence. Am J Clin Dermatol. 2018 Aug;19(4):459-477. doi: 10.1007/s40257-018-0358-5.
  7. Cowin AJ, Brosnan MP, Holmes TM, Ferguson MW. Endogenous inflammatory response to dermal wound healing in the fetal and adult mouse. Dev Dyn. 1998 Jul;212(3):385-93. doi: 10.1002/(SICI)1097-0177(199807)212:3<385::AID-AJA6>3.0.CO;2-D.
  8. Martin P, Leibovich SJ. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol. 2005 Nov;15(11):599-607. doi: 10.1016/j.tcb.2005.09.002. 
  9. Baum CL, Arpey CJ. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg. 2005 Jun;31(6):674-86; discussion 686. doi: 10.1111/j.1524-4725.2005.31612.
  10. Midwood KS, Williams LV, Schwarzbauer JE. Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol. 2004 Jun;36(6):1031-7. doi: 10.1016/j.biocel.2003.12.003. 
  11. Gupta A, Kaur M, Patra S, Khunger N, Gupta S. Evidence-based Surgical Management of Post-acne Scarring in Skin of Color. J Cutan Aesthet Surg. 2020 Apr-Jun;13(2):124-141. doi: 10.4103/JCAS.JCAS_154_19. 
  12. Jacob CI, Dover JS, Kaminer MS. Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol. 2001 Jul;45(1):109-17. doi: 10.1067/mjd.2001.113451.
  13. Goodman GJ, Baron JA. Postacne scarring: a qualitative global scarring grading system. Dermatol Surg. 2006 Dec;32(12):1458-66. doi: 10.1111/j.1524-4725.2006.32354.x. 
  14. Fabbrocini G, Annunziata MC, D'Arco V, De Vita V, Lodi G, Mauriello MC, Pastore F, Monfrecola G. Acne scars: pathogenesis, classification and treatment. Dermatol Res Pract. 2010;2010:893080. doi: 10.1155/2010/893080.
  15. Shen YC, Chiu WK, Kang YN, Chen C. Microneedling Monotherapy for Acne Scar: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Aesthetic Plast Surg. 2022 Aug;46(4):1913-1922. doi: 10.1007/s00266-022-02845-3. 
  16. Long T, Gupta A, Ma S, Hsu S. Platelet-rich plasma in noninvasive procedures for atrophic acne scars: A systematic review and meta-analysis. J Cosmet Dermatol. 2020 Apr;19(4):836-844. doi: 10.1111/jocd.13331.
  17. Lin L, Liao G, Chen J, Chen X. A systematic review and meta-analysis on the effects of the ultra-pulse CO2 fractional laser in the treatment of depressed acne scars. Ann Palliat Med. 2022 Feb;11(2):743-755. doi: 10.21037/apm-22-70.
  18. Kontochristopoulos G, Platsidaki E. Chemical peels in active acne and acne scars. Clin Dermatol. 2017 Mar-Apr;35(2):179-182. doi: 10.1016/j.clindermatol.2016.10.011. 
  19. Berman B, Perez OA, Konda S, Kohut BE, Viera MH, Delgado S, Zell D, Li Q. A review of the biologic effects, clinical efficacy, and safety of silicone elastomer sheeting for hypertrophic and keloid scar treatment and management. Dermatol Surg. 2007 Nov;33(11):1291-302; discussion 1302-3. doi: 10.1111/j.1524-4725.2007.33280.x. 
  20. Atiyeh BS. Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods. Aesthetic Plast Surg. 2007 Sep-Oct;31(5):468-92; discussion 493-4. doi: 10.1007/s00266-006-0253-y. 
  21. Layton AM, Yip J, Cunliffe WJ. A comparison of intralesional triamcinolone and cryosurgery in the treatment of acne keloids. Br J Dermatol. 1994 Apr;130(4):498-501. doi: 10.1111/j.1365-2133.1994.tb03385.x. 
  22. Keaney TC, Tanzi E, Alster T. Comparison of 532 nm Potassium Titanyl Phosphate Laser and 595 nm Pulsed Dye Laser in the Treatment of Erythematous Surgical Scars: A Randomized, Controlled, Open-Label Study. Dermatol Surg. 2016 Jan;42(1):70-6. doi: 10.1097/DSS.0000000000000582.
  23. Wolfram D, Tzankov A, Pülzl P, Piza-Katzer H. Hypertrophic scars and keloids--a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg. 2009 Feb;35(2):171-81. doi: 10.1111/j.1524-4725.2008.34406.x. 
  24. Campese VM. Minoxidil: a review of its pharmacological properties and therapeutic use. Drugs. 1981 Oct;22(4):257-78. doi: 10.2165/00003495-198122040-00001.
  25. Panchaprateep R, Lueangarun S. Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment. Dermatol Ther (Heidelb). 2020 Dec;10(6):1345-1357. doi: 10.1007/s13555-020-00448-x. 
  26. Cranwell W, Sinclair R. Male androgenetic alopecia. In: KR Feingold, B Anawalt, A Boyce, et al, eds. Endotext., Inc.; 2016.
  27. Rossi A, Anzalone A, Fortuna MC, Caro G, Garelli V, Pranteda G, Carlesimo M. Multi-therapies in androgenetic alopecia: review and clinical experiences. Dermatol Ther. 2016 Nov;29(6):424-432. doi: 10.1111/dth.12390.
  28. Blume-Peytavi U, Hillmann K, Dietz E, Canfield D, Garcia Bartels N. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. J Am Acad Dermatol. 2011 Dec;65(6):1126-1134.e2. doi: 10.1016/j.jaad.2010.09.724. 
  29. Price VH, Menefee E, Strauss PC. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment. J Am Acad Dermatol. 1999 Nov;41(5 Pt 1):717-21. doi: 10.1016/s0190-9622(99)70006-x. 
  30. Shao S, Zhang X, Duan L, Fang H, Rao S, Liu W, Guo B, Zhang X. Lysyl Hydroxylase Inhibition by Minoxidil Blocks Collagen Deposition and Prevents Pulmonary Fibrosis via TGF-β₁/Smad3 Signaling Pathway. Med Sci Monit. 2018 Nov 27;24:8592-8601. doi: 10.12659/MSM.910761.
  31. Hautala T, Heikkinen J, Kivirikko KI, Myllylä R. Minoxidil specifically decreases the expression of lysine hydroxylase in cultured human skin fibroblasts. Biochem J. 1992 Apr 1;283 ( Pt 1)(Pt 1):51-4. doi: 10.1042/bj2830051. 
  32. Murad S, Walker LC, Tajima S, Pinnell SR. Minimum structural requirements for minoxidil inhibition of lysyl hydroxylase in cultured fibroblasts. Arch Biochem Biophys. 1994 Jan;308(1):42-7. doi: 10.1006/abbi.1994.1006.
  33. van der Slot AJ, van Dura EA, de Wit EC, De Groot J, Huizinga TW, Bank RA, Zuurmond AM. Elevated formation of pyridinoline cross-links by profibrotic cytokines is associated with enhanced lysyl hydroxylase 2b levels. Biochim Biophys Acta. 2005 Jun 30;1741(1-2):95-102. doi: 10.1016/j.bbadis.2004.09.009.
  34. Remst DF, Blaney Davidson EN, Vitters EL, Blom AB, Stoop R, Snabel JM, Bank RA, van den Berg WB, van der Kraan PM. Osteoarthritis-related fibrosis is associated with both elevated pyridinoline cross-link formation and lysyl hydroxylase 2b expression. Osteoarthritis Cartilage. 2013 Jan;21(1):157-64. doi: 10.1016/j.joca.2012.10.002. 
  35. Zuurmond AM, van der Slot-Verhoeven AJ, van Dura EA, De Groot J, Bank RA. Minoxidil exerts different inhibitory effects on gene expression of lysyl hydroxylase 1, 2, and 3: implications for collagen cross-linking and treatment of fibrosis. Matrix Biol. 2005 Jun;24(4):261-70. doi: 10.1016/j.matbio.2005.04.002.
  36. Shao S, Fang H, Duan L, Ye X, Rao S, Han J, Li Y, Yuan G, Liu W, Zhang X. Lysyl hydroxylase 3 increases collagen deposition and promotes pulmonary fibrosis by activating TGFβ1/Smad3 and Wnt/β-catenin pathways. Arch Med Sci. 2019 Jan 16;16(2):436-445. doi: 10.5114/aoms.2018.81357.
  37. Priestley GC, Lord R, Stavropoulos P. The metabolism of fibroblasts from normal and fibrotic skin is inhibited by minoxidil in vitro. Br J Dermatol. 1991 Sep;125(3):217-21. doi: 10.1111/j.1365-2133.1991.tb14743.x.
  38. Knitlova J, Doubkova M, Plencner M, Vondrasek D, Eckhardt A, Ostadal M, Musilkova J, Bacakova L, Novotny T. Minoxidil decreases collagen I deposition and tissue-like contraction in clubfoot-derived cells: a way to improve conservative treatment of relapsed clubfoot? Connect Tissue Res. 2021 Sep;62(5):554-569. doi: 10.1080/03008207.2020.1816992. 
  39. Freiha M, Achim M, Gheban BA, Moldovan R, Filip GA. In Vivo Study of the Effects of Propranolol, Timolol, and Minoxidil on Burn Wound Healing in Wistar Rats. J Burn Care Res. 2023 Apr 26:irad057. doi: 10.1093/jbcr/irad057.
  40. Polo M, Hill DP Jr, Carney G, Ko F, Wright TE, Robson MC. Minoxidil and wound contraction. Ann Plast Surg. 1997 Sep;39(3):292-8. doi: 10.1097/00000637-199709000-00012. 

Download Article
Received July 7, 2023.
Accepted August 28, 2023.
©2023 International Medical Research and Development Corporation.